You did the responsible thing. You saw a doctor, you got the prescription, you take the pill every single morning like you're supposed to. And you are still limping around on a hot, swollen toe wondering what the point was. Somewhere between disappointment and betrayal, you start Googling "why isn't allopurinol working" at your desk, or worse, at 3am with your foot outside the covers again.
I read this exact question in the gout communities more than almost any other, usually from someone who did everything right and is starting to lose faith in the one tool that was supposed to be reliable. There are three honest reasons this happens, and every one of them is invisible until you actually know your number.
Am I actually at target on allopurinol?
Probably not, and that is the single biggest reason people think their medication has failed them. A "normal" uric acid result on a standard lab report is not the same thing as the gout target. Labs report a wide reference range that can call 7.0 mg/dL, even 7.5, "normal," because that range is built for the general population, not for someone whose joints already have crystals sitting in them. The American College of Rheumatology's own patient guide states the actual goal plainly: get your uric acid to 6.0 mg/dL or lower to dissolve or prevent crystals. A "normal" lab result does not mean your uric acid is low enough to stop flares.
There is no fixed correct dose of allopurinol. The right dose is whatever gets you under that 6.0 mg/dL line, which is why the standard approach is a blood test every two to five weeks after starting or changing a dose, adjusting until you are under target, you hit the maximum dose, or side effects show up. If nobody has retested you and pushed the dose since your first prescription, undertreatment is a far more likely explanation than the drug not working. That is exactly what our free uric acid interpreter exists to catch in about a minute: give it your last result, in mg/dL, mmol/L, or µmol/L, and it shows you plainly whether you are actually under the line.
How long does allopurinol take to actually work?
Longer than most people are told, and that gap is where a lot of people quit too early. Even once you are genuinely at target, it can take six to twelve months before flares get noticeably less frequent, shorter, and milder. The crystals in your joints took years to build up, and getting your uric acid low enough for them to slowly dissolve is a matter of months, not days. A rheumatology practice that fields this exact question walks patients through the same honest timeline: reaching target is step one, and fewer attacks follow gradually after that, not immediately.
That is a long stretch to hold your nerve through if the drug seems to be doing nothing so far. "No visible change yet" at month two is normal, not a red flag. The real test is whether your actual number has moved, not whether your toe has stopped talking to you.
Why do flares get worse right after starting allopurinol?
Because it is working, not because it is failing, and this is the part almost nobody warns people about before they start. As your uric acid level drops, the crystals already sitting in your joints start to shift and shed instead of sitting quietly, and that disturbance itself can set off a flare. One rheumatology explainer describes it plainly: starting and stopping allopurinol, or changing the dose, can stir up old crystals and set off exactly the kind of attack you started the drug to prevent. It is a well documented and expected part of early treatment, not a sign the medication chose the wrong side.
This is exactly why the ACR treatment guideline strongly recommends a second, short-term medication like colchicine, an anti-inflammatory, or a low-dose steroid right alongside allopurinol for the first three to six months, specifically to smooth over this window. If nobody offered you that and you are flaring more since starting, that is a fair thing to raise at your next visit, not a reason to quit on your own. A few honest questions worth bringing instead of a decision made alone: whether short-term prophylaxis alongside the allopurinol makes sense for you, whether starting lower and titrating up slowly would ease the transition, and whether your dose has actually been retested since your uric acid was last checked. None of those are instructions from me. They are your doctor's call, and raising them is how the plan matches what the evidence says works. If you want those questions written down before the appointment, I keep mine on a free page about talking to your doctor.
One more thing worth knowing, because it contradicts advice still floating around online: some doctors used to hold off starting allopurinol during an active flare. Current guidance actually allows starting it during a flare when appropriate, alongside that same short-term cover. If a flare has you wondering whether to pause a dose you just started, that is a conversation for your doctor, not a decision to make solo on a bad night. Stopping a urate-lowering drug abruptly, for any reason, tends to send your uric acid right back up and can trigger the very flare you were trying to avoid.
What if I get a rash after starting allopurinol?
Everything above this point argues for patience. This is the one situation that runs the other way, and it is worth knowing before it happens rather than after.
A new rash after starting allopurinol is not part of the normal adjustment. Neither are mouth sores, facial swelling, or a fever arriving alongside them. That combination can be the beginning of a serious reaction to the drug itself, which doctors call an allopurinol hypersensitivity reaction, and it is the one thing here that does not wait for your next appointment. The standard medical guidance is to stop and contact whoever prescribed it the same day, which is the opposite of everything else on this page. If you cannot reach them and it is getting worse, that is urgent care or the emergency room.
This is uncommon and I am not telling you to expect it. I am telling you because the rest of this article makes the case for holding steady, and holding steady is the wrong instinct here. Flares while your number comes down are expected and you ride those out. A rash is a different signal and it gets a phone call.
None of these three answers is guessable from how you feel. You cannot tell undertreatment from impatience from a normal initiation flare by symptoms alone. The only way to know which one you are dealing with is your actual number, tracked over time. If you have a result sitting in a patient portal right now, run it through the free interpreter and see exactly where you stand against target. If you have never been tested outside a doctor's office, here is how people are getting it done without waiting on an appointment.
Common questions
Can I just take a double dose if a flare breaks through on allopurinol?
No, and this is one of two instincts that makes things worse, along with quitting outright. A flare while you are on the medication is not proof it is failing, so doubling up does not fix anything and is not a decision to make on your own. If flares keep breaking through, raise it with your doctor: your actual number, and whether the dose or timeline needs adjusting.
Does febuxostat have the same starting-flare problem as allopurinol?
Yes. Both are daily uric acid-lowering drugs working the same way, and both can trigger the same initiation flares as old crystals start to dissolve. The same short-term cover and patience through the first several months applies either way.
My uric acid is under 6.0 mg/dL but I'm still flaring occasionally. Is something wrong?
Not necessarily. Getting under target stops new crystals forming and starts the slow dissolving process, but existing crystals take months to clear, and occasional flares during that window are expected. Frequent or worsening flares, or a number not rechecked lately, are worth flagging at your next appointment.